Onychomycosis; potentially increasing diagnostic sensitivity with a 6-week nail-clipping collection

Review of efficacy, safety and management considerations of tofacitinib: Emerging evidence and key clinical-considerations for JAK-inhibitor use in dermatology

The distinct clinical and histologic profiles of lightened melanocytic naevi under BRAF-inhibitor and trametinib combination versus anti-PD1 immunotherapy